ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,578.01
4.60%
S&P 500
5,636.85
0.38%
Dow Jones
40,249.60
0.62%
US Dollar vs Yen
157.85
-0.30%
Brent Oil
84.365
-0.27%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Ritter Pharmaceuticals Inc (RTTR)

  7. Ritter Pharmaceuticals Inc (RTTR) ニュース

RTTR

Ritter Pharmaceuticals (RTTR)

Ritter Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:RTTR
日付受信時刻ニュースソース見出しコード企業名
2019/11/0720 : 03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/11/0720 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/11/0205 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/10/1605 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/10/0722 : 00GlobeNewswire Inc.Ritter Pharmaceuticals Engages Financial Advisor to Explore Strategic AlternativesNASDAQ:RTTRRitter Pharmaceuticals Inc
2019/09/1906 : 28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/09/1305 : 30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/09/1305 : 15GlobeNewswire Inc.Ritter Pharmaceuticals Reports Top-Line Results from its Liberatus Phase 3 Trial of RP-G28 for Lactose IntoleranceNASDAQ:RTTRRitter Pharmaceuticals Inc
2019/08/2406 : 00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/08/1506 : 15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/08/1506 : 13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/08/1506 : 11GlobeNewswire Inc.Ritter Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2019 and Provides a Corporate Up...NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/08/1322 : 15GlobeNewswire Inc.Ritter Pharmaceuticals Appoints Esteemed Gastroenterologist Anthony J. Lembo, M.D. to its Medical Advisory BoardNASDAQ:RTTRRitter Pharmaceuticals Inc
2019/08/0903 : 16GlobeNewswire Inc.Ritter Pharmaceuticals Provides Highlights from Lactose Intolerance Market Research CallNASDAQ:RTTRRitter Pharmaceuticals Inc
2019/08/0705 : 46Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/08/0219 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/08/0219 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/07/3122 : 00GlobeNewswire Inc.Ritter Pharmaceuticals Hosts Conference Call on August 7, 2019 to Highlight Recent Lactose Intolerance Market Research Findin...NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/07/2522 : 19Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/07/2506 : 29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/07/2506 : 10Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/07/1206 : 28GlobeNewswire Inc.Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Minimum Bid Price RequirementNASDAQ:RTTRRitter Pharmaceuticals Inc
2019/07/1206 : 23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/07/0222 : 00GlobeNewswire Inc.Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose ...NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/07/0205 : 49Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/06/2022 : 15GlobeNewswire Inc.Ritter Pharmaceuticals Provides Phase 3 Liberatus Clinical Trial and Regulatory UpdateNASDAQ:RTTRRitter Pharmaceuticals Inc
2019/06/1805 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/05/3020 : 00GlobeNewswire Inc.Ritter Pharmaceuticals Shares New Market Research Illuminating the Life Challenges of a Lactose Intolerance SuffererNASDAQ:RTTRRitter Pharmaceuticals Inc
2019/05/1605 : 13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RTTRRitter Pharmaceuticals Inc
2019/05/1605 : 10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RTTRRitter Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RTTR

最近閲覧した銘柄

CCOM
US100
US Tech 100
AMEX
XLV
Health Care Select Sector
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
AMEX
XLF
Financial Select Sector
NYSE
BAC
Bank of America
COIN
SOLUSD
Solana
NYSE
NKE
Nike
FX
USDEUR
US Dollar vs Euro
COIN
BTCUSD
Bitcoin
USOTC
BASFY
BASF (QX)
NASDAQ
AAPL
Apple
CCOM
US30
US 30
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有